Research Article
HER2 Testing Characteristics Can Predict Residual Cancer Burden following Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer
Table 1
ASCO/CAP guidelines categorize HER2 FISH results into 5 groups based on HER2/CEP17 ratio and average HER2 copy number.
|